Activate Advanced Contamination Control Technology To Safeguard Your Cell Therapy

By Alexandra Lisi, Global Applications and Technical Marketing Manager, Cell Therapy, and Sandi True, Field Application Specialist, Thermo Fisher Scientific

Contamination control is a critical challenge in cell therapy manufacturing, where complex workflows, open processing steps, and zero tolerance for failure place both product integrity and patient safety at risk. Thus, it is critical to implement a comprehensive, end-to-end contamination mitigation strategy that integrates closed-system processing, scalable automation, and rapid in-process testing across the full cell therapy lifecycle.

Thermo Fisher Scientific’s latest technologies enable manufacturers to reduce open handling, minimize human error, and accelerate decision-making without compromising regulatory compliance. The intent is to prioritize early and frequent contamination monitoring that is backed by fast, sensitive qPCR-based methods that support short shelf-life products and real-time release strategies. Download the full article to explore how combining advanced manufacturing platforms with robust analytical and environmental monitoring solutions can help cell therapy developers improve consistency, safeguard product quality, and accelerate the qualification and commercialization of life-changing therapies.